AGN : Summary for Allergan plc Ordinary Shares - Yahoo Finance

U.S. Markets closed

Allergan plc (AGN)

NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
245.23+0.41 (+0.17%)
At close: 4:00PM EST

245.29 0.06 (0.02%)
After hours: 4:00PM EST

People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close244.82
Bid0.00 x
Ask0.00 x
Day's Range242.44 - 246.74
52 Week Range184.50 - 299.11
Avg. Volume4,001,523
Market Cap91.98B
PE Ratio (TTM)6.42
Earnings DateN/A
Dividend & Yield2.80 (1.14%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journalsyesterday

    The eyes have it in Allergan's new ad campaign from FCB Chicago

    Titled "Eyepowerment," the new campaign is intended to make the public more attuned to chronic dry eye, a problem that reportedly afflicts some 33 million Americans. Close-up images of Lucille Ball, Bette Davis, Amelia Earhart, Maya Angelou and Rosa Parks are among those included in the new spot which debuted this past weekend on social media platforms.

  • Drugmakers pledge restraint, but prices will still soar
    Associated Press2 days ago

    Drugmakers pledge restraint, but prices will still soar

    TRENTON, N.J. (AP) — Several big drugmakers are trying to quell the furor over high drug prices by revealing more information about their pricing and even pledging to keep a lid on increases.

  • PR Newswire2 days ago

    Allergan to Present at Raymond James 38th Annual Institutional Investors Conference

    DUBLIN, Feb. 27, 2017 /PRNewswire/ -- Allergan plc (AGN) a leading global pharmaceutical company, today announced that Bill Meury, Allergan's Chief Commercial Officer, will present at the Raymond James 38th Annual Institutional Investors Conference in Orlando, Florida. The presentation will be webcast live and can be accessed on Allergan's Investor Relations web site at Allergan plc (AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma.  Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world.